Responses of somatostatin, beta-endorphin and dynorphin A to a glucose load in two groups of women with polycystic ovarian syndrome
- PMID: 8871183
- DOI: 10.1159/000184997
Responses of somatostatin, beta-endorphin and dynorphin A to a glucose load in two groups of women with polycystic ovarian syndrome
Abstract
To investigate the relationship between elevated LH, hyperinsulinemia and neuropeptides in polycystic ovarian syndrome (PCOS), we measured the endogenous levels of insulin, somatostatin (SS), beta-endorphin (beta-EP) and dynorphin A (Dyn A) before and after a glucose load in three groups: group 1 (LH/ FSH > or = 3, n = 30); group 2 (LH/FSH < 3, n = 25), and controls (n = 15). In the basal state, significantly negative correlations were found between LH and SS (r = -0.51, p < 0.05) in group 1 and between LH and beta-EP (r = -0.49, p < 0.05) in group 2. After a glucose load, PCOS women had greater beta-EP and Dyn A responses in group 1 and impaired SS response in group 2 as compared with the control. The data suggest endogenously lower SS, higher beta-EP and Dyn A may contribute to the elevation of LH and insulin secretions in PCOS.
Similar articles
-
[Responses of somatostatin, beta-endorphin and dynorphin A to A glucose load in two groups of women with polycystic ovarian syndrome].Zhonghua Fu Chan Ke Za Zhi. 1995 Dec;30(12):728-31. Zhonghua Fu Chan Ke Za Zhi. 1995. PMID: 8728917 Clinical Trial. Chinese.
-
Insulin, C-peptide, androgens, and beta-endorphin response to oral glucose in patients with polycystic ovary syndrome.J Clin Endocrinol Metab. 1994 Feb;78(2):305-9. doi: 10.1210/jcem.78.2.8106616. J Clin Endocrinol Metab. 1994. PMID: 8106616
-
Insulin, somatotropic, and luteinizing hormone axes in lean and obese women with polycystic ovary syndrome: common and distinct features.J Clin Endocrinol Metab. 1996 Aug;81(8):2854-64. doi: 10.1210/jcem.81.8.8768842. J Clin Endocrinol Metab. 1996. PMID: 8768842
-
Loss of LH-induced down-regulation of anti-Müllerian hormone receptor expression may contribute to anovulation in women with polycystic ovary syndrome.Hum Reprod. 2013 Mar;28(3):762-9. doi: 10.1093/humrep/des460. Epub 2013 Jan 14. Hum Reprod. 2013. PMID: 23321213
-
The origins and sequelae of abnormal neuroendocrine function in polycystic ovary syndrome.Hum Reprod Update. 2006 Jul-Aug;12(4):351-61. doi: 10.1093/humupd/dml017. Epub 2006 May 2. Hum Reprod Update. 2006. PMID: 16670102 Review.
Cited by
-
Nonhuman primates as models for human adrenal androgen production: function and dysfunction.Rev Endocr Metab Disord. 2009 Mar;10(1):33-42. doi: 10.1007/s11154-008-9099-8. Rev Endocr Metab Disord. 2009. PMID: 18683055 Free PMC article. Review.
-
Fetal programming of adrenal androgen excess: lessons from a nonhuman primate model of polycystic ovary syndrome.Endocr Dev. 2008;13:145-158. doi: 10.1159/000134831. Endocr Dev. 2008. PMID: 18493139 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical